Rapid Micro Biosystems delays third-quarter report, expects filing by Nov. 23
RPID•
RPID•Rapid Micro Biosystems expects to file its September 30, 2026, quarterly report by November 23 after delaying it. Preliminary revenue is expected to rise 21.6% to $9.5 million, while limited liquidity raises substantial doubt about its ability to continue as a going concern.
Rapid Micro Biosystems delayed its quarterly report for the period ended September 30, 2026, and expects to file it by November 23. Work on potential financing opportunities and strategic transactions diverted resources from preparing the report, and the definitive agreement to be acquired by Merck KGaA requires significant disclosure updates.
The company said limited liquidity raises substantial doubt about its ability to continue as a going concern, and completion of the acquisition remains uncertain. Preliminary quarterly revenue is expected to rise 21.6% to $9.5 million from $7.8 million a year earlier.